Currently a professor at the Keck School of Medicine of the University of Southern California and the Director of the USC Clinical Diabetes Programs, Dr. Anne L. Peters has worked in the field of diabetes prevention through extensive involvement with multiple clinical trials, NIH grants, over 100 articles in peer-reviewed medical journals, and speaking engagements across the globe.
While concurrently directing diabetes centers in Beverly Hills and in underserved East Los Angeles, Dr. Peters works with the LA County Department of Health Services on the institution of a county-wide diabetes program. Dr. Peters has previously served as director of the clinical diabetes programs at Cedars-Sinai Medical Center and UCLA before her tenure at USC, after receiving her medical degree from the Pritzker School of Medicine at the University of Chicago, performing an internal medicine residency at Stanford University and Harbor UCLA Medical Center, and a fellowship in endocrinology at Cedars-Sinai.
Dr. Peters has served as a principal investigator on multiple clinical trials focused on diabetes prevention, and is currently involved with three NIH grants aimed at curbing and reducing heart disease and diabetes. Dr. Peters has additionally established the Community Diabetes Initiatives Research Center in collaboration with Children’s Hospital Los Angeles. She has authored three books on diabetes, in addition to articles that have appeared in JAMA, The New England Journal of Medicine, Annals of Internal Medicine, and Diabetes Care.
Dr. Peters serves on the ABIM Endocrine Board, multiple ADA committees, and the EASD/ADA Diabetes Technology Committee. She was the recipient of the ADA Outstanding Physician Clinician Award in 2008, and the 2010 Bernardo Houssay Award from the National Minority Quality Forum for her work with underserved populations. Dr. Peters has of the ADA/EASD Position Statement on “Management of Hyperglycemia in Type 2 Diabetes,” and the ADA Position Statement on “Treatment of Type 1 Diabetes Across the Lifespan.”
Join us in San Diego on May 6th for the CMHC Regional Conference, and hear Dr. Peters and colleagues address “T2DM Updates in Treatment and Cardiovascular Outcomes and Trials” while providing updates on current and emerging therapies, treatment guidelines, and strategies to improve clinical outcomes.
